>>Signaling Pathways>> GPCR/G protein>> Melanocortin (MC) Receptors>>MSG 606

MSG 606

Catalog No.GC50303

MSG 606은 human melanocortin 1 receptor (hMC1R)에 대한 강력한 항작용 활동과 수용체 선택성을 가지고 있다(IC50 = 17 nM).

Products are for research use only. Not for human use. We do not sell to patients.

MSG 606 Chemical Structure

Cas No.: 1416983-77-1

Size 가격 재고 수량
1 mg
US$215.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

MSG 606은 human melanocortin 1 receptor (hMC1R)에 대한 강력한 항작용 활동과 수용체 선택성을 가지고 있다(IC50 = 17 nM).

MSG-606은 피부암 진단에서 특히 멜라놈세포를 특이적으로 타겟팅하기 위한 뛰어난 탐지제이다. MSG-606은 멜라놈 세포에 대한 항작용제로 작용합니다. MSG-606은 인간 멜라놈 세포(A375)에 대한 결합 및 cAMP 활동을 통해 IC50 96 nM [1]을 달성한다.

MSG-606(1nmol/µl, 6µl)은 subarachnoid hemorrhage (SAH )모델에서 BMS-470539/MC1R 시스템의 신경 보호 작용을 막했다[2].

References:
[1]:Cai M, Stankova M, Muthu D, et al. An unusual conformation of γ-melanocyte-stimulating hormone analogues leads to a selective human melanocortin 1 receptor antagonist for targeting melanoma cells[J]. Biochemistry, 2013, 52(4): 752-764.
[2]:Xu, W., Mo, J., Ocak, U. et al. Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats. Neurotherapeutics 17, 294-308 (2020). https://doi.org/10.1007/s13311-019-00772-x

리뷰

Review for MSG 606

Average Rating: 5 ★★★★★ (Based on Reviews and 4 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MSG 606

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.